Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention/Experiment 6/Signature 1
From BugSigDB
< Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention | Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention/Experiment 6
Reviewed Marked as Reviewed by Svetlana up on 2025-1-30
Source: Figure 2b, c, d & Figure 3e
Description: Microbiota composition at the phylum, family, and genus level and the relative abundance of signatures among four groups.
Abundance in Group 1: increased abundance in Polycystic ovary syndrome + Semaglutide group (PCOS + Semaglutide)
| NCBI | Quality Control | Links |
|---|---|---|
| Campylobacterota | ||
| Helicobacteraceae | ||
| Helicobacter | ||
| Alistipes muris |
Revision editor(s): Victoria
